Groundbreaking genomic test could spare millions of breast cancer patients chemotherapy

Groundbreaking genomic test could spare millions of breast cancer patients chemotherapy

Trial suggests patients with a low test score could be treated with hormone therapy alone with near-identical outcomes ‘Like Christmas’: woman’s relief after test finds she can skip chemotherapy...

Redirecting to full article...